Copyright
©The Author(s) 2021.
World J Hepatol. Dec 27, 2021; 13(12): 2137-2149
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2137
Published online Dec 27, 2021. doi: 10.4254/wjh.v13.i12.2137
Figure 1 Bioinformatic search and validation of the newly diagnostic biomarkers.
A: miR-519d-3p and SQSTM1 as a targeted mRNA according to miRDB (http://mirdb.org/cgi-bin/search.cgi?searchType=miRNA&full=mirbase&searchBox=MIMAT0002853); B: A network of 923 genes targeted by hsa-miR-519d-3p, along with focusing on SQSTM1 in the network (miRTargetLink Human) (https://ccb-web.cs.uni-saarland.de/mirtargetlink/network.php?type=miRNA&qval=hsa-miR-519d-3p); C: The expression of miR-519d in liver tissue and other tissues (https://www.genecards.org/); D: The tissue expression of SQSTM1 is low in hepatocytes of healthy liver tissue (www.proteinatlas.org); E: The expression of SQSTM1 in cancers and liver cancer specifically (www.proteinatlas.org).
- Citation: Yosef T, Ibrahim WA, Matboli M, Swilam AA, El-Nakeep S. New stem cell autophagy surrogate diagnostic biomarkers in early-stage hepatocellular carcinoma in Egypt: A pilot study . World J Hepatol 2021; 13(12): 2137-2149
- URL: https://www.wjgnet.com/1948-5182/full/v13/i12/2137.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i12.2137